Anticoagulant Citrate Dextrose (acd-a) Solution
NDC Package 14537-820-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Anticoagulant Citrate Dextrose (acd-a) (dextrose monohydrate, sodium citrate, unspecified form, and citric acid monohydrate) solution is aNTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is an anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. This formulation utilizes a solution delivery system. Marketed by Terumo Bct, Ltd, this product is identified by NDC 14537-820 and is authorized under FDA application BA110057.

Identification & Billing

NDC Package Code
14537-820-03
Package Description
50 POUCH in 1 CASE / 1 BAG in 1 POUCH (14537-820-01) / 50 mL in 1 BAG (14537-820-00)
Product Code
14537-820
11-Digit Billing Format
14537082003

Clinical Specifications

Proprietary Name
Anticoagulant Citrate Dextrose (acd-a)
Non-Proprietary Name
Dextrose Monohydrate, Sodium Citrate, Unspecified Form, And Citric Acid Monohydrate
Substance Name
Citric Acid Monohydrate; Dextrose Monohydrate; Sodium Citrate, Unspecified Form
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is an anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. [See Dosage and Administration (2).]

Regulatory & Marketing

Labeler Name
Terumo Bct, Ltd
Product Type
Human Prescription Drug
FDA Application #
BA110057
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-18-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14537-820-03 identifies a specific commercial package of 50 pouch in 1 case / 1 bag in 1 pouch (14537-820-01) / 50 ml in 1 bag (14537-820-00) of Anticoagulant Citrate Dextrose (acd-a), a human prescription drug labeled by Terumo Bct, Ltd. This solution is formulated for intravenous use and contains citric acid monohydrate; dextrose monohydrate; sodium citrate, unspecified form as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Terumo Bct, Ltd on July 18, 2023. The current certification is valid through December 31, 2026.

How is this Terumo Bct, Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14537082003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
14537-820-03
11-Digit CMS (5-4-2)
14537-0820-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.